| Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries A Angelis, A Lange, P Kanavos The European Journal of Health Economics 19, 123-152, 2018 | 318 | 2018 |
| Socio-economic burden of rare diseases: a systematic review of cost of illness evidence A Angelis, D Tordrup, P Kanavos Health Policy 119 (7), 964-979, 2015 | 317 | 2015 |
| Multiple criteria decision analysis (MCDA) for evaluating new medicines in health technology assessment and beyond: the advance value framework A Angelis, P Kanavos Social Science & Medicine 188, 137-156, 2017 | 223 | 2017 |
| Pars plana vitrectomy for vitreomacular traction syndrome: a systematic review and metaanalysis of safety and efficacy TL Jackson, E Nicod, A Angelis, F Grimaccia, AT Prevost, ARH Simpson, ... Retina 33 (10), 2012-2017, 2013 | 129 | 2013 |
| Symptomatic vitreomacular adhesion TL Jackson, E Nicod, A Simpson, A Angelis, F Grimaccia, P Kanavos Retina 33 (8), 1503-1511, 2013 | 119 | 2013 |
| Value-based assessment of new medical technologies: towards a robust methodological framework for the application of multiple criteria decision analysis in the context of … A Angelis, P Kanavos Pharmacoeconomics 34 (5), 435-446, 2016 | 105 | 2016 |
| Vitreous attachment in age-related macular degeneration, diabetic macular edema, and retinal vein occlusion: a systematic review and metaanalysis TL Jackson, E Nicod, A Angelis, F Grimaccia, AT Prevost, ARH Simpson, ... Retina 33 (6), 1099-1108, 2013 | 99 | 2013 |
| Pars plana vitrectomy for diabetic macular edema: a systematic review, meta-analysis, and synthesis of safety literature TL Jackson, E Nicod, A Angelis, F Grimaccia, E Pringle, P Kanavos Retina 37 (5), 886-895, 2017 | 84 | 2017 |
| Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe A Angelis, P Kanavos, J López-Bastida, R Linertová, J Oliva-Moreno, ... The European Journal of Health Economics 17, 31-42, 2016 | 80 | 2016 |
| Social and economic costs and health-related quality of life in non-institutionalised patients with cystic fibrosis in the United Kingdom A Angelis, P Kanavos, J López-Bastida, R Linertová, E Nicod, ... BMC health services research 15, 1-8, 2015 | 72 | 2015 |
| Resource allocation and priority setting in health care: a multi‐criteria decision analysis problem of value? A Angelis, P Kanavos, G Montibeller Global Policy 8, 76-83, 2017 | 71 | 2017 |
| Common elements in rare kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference S Aymé, D Bockenhauer, S Day, O Devuyst, LM Guay-Woodford, ... Kidney international 92 (4), 796-808, 2017 | 59 | 2017 |
| Applying multiple criteria decision analysis to comparative benefit-risk assessment: choosing among statins in primary prevention T Tervonen, H Naci, G van Valkenhoef, AE Ades, A Angelis, HL Hillege, ... Medical Decision Making 35 (7), 859-871, 2015 | 58 | 2015 |
| The economic burden and health-related quality of life associated with systemic sclerosis in France K Chevreul, KB Brigham, C Gandré, L Mouthon, ... Scandinavian journal of rheumatology 44 (3), 238-246, 2015 | 51 | 2015 |
| Costs and health-related quality of life of patients with cystic fibrosis and their carers in France K Chevreul, KB Brigham, M Michel, G Rault, BRDR Network Journal of Cystic Fibrosis 14 (3), 384-391, 2015 | 50 | 2015 |
| Multiple criteria decision analysis in the context of health technology assessment: a simulation exercise on metastatic colorectal cancer with multiple stakeholders in the … A Angelis, G Montibeller, D Hochhauser, P Kanavos BMC Medical Informatics and Decision Making 17, 1-25, 2017 | 37 | 2017 |
| Multiple criteria decision analysis for HTA across four EU member states: piloting the advance value framework A Angelis, M Linch, G Montibeller, T Molina-Lopez, A Zawada, K Orzel, ... Social Science & Medicine 246, 112595, 2020 | 36 | 2020 |
| Socioeconomic costs and health-related quality of life in juvenile idiopathic arthritis: a cost-of-illness study in the United Kingdom A Angelis, P Kanavos, J López-Bastida, R Linertová, P Serrano-Aguilar BMC musculoskeletal disorders 17, 1-9, 2016 | 33 | 2016 |
| Recalibrating health technology assessment methods for cell and gene therapies A Angelis, H Naci, A Hackshaw Pharmacoeconomics 38 (12), 1297-1308, 2020 | 31 | 2020 |
| Preferences on policy options for ensuring the financial sustainability of health care services in the future: results of a stakeholder survey D Tordrup, A Angelis, P Kanavos Applied health economics and health policy 11, 639-652, 2013 | 30 | 2013 |
Panos KanavosAssociate Professor in International Health PolicyVerified email at lse.ac.uk
